Symbols

IMCR

Immunocore·NASDAQ

--(--)

6.39 / 10

Outperform

Sentiment score 6.39 (Outperform) and fund‑flow score 7.96 indicate strong buying pressure. Analysts are split 50% Strong Buy and 50% Neutral, yet the stock fell 4.6%, reflecting mixed expectations.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

50%

Buy

Hold

Sell

Strong Sell

Date2026-03-16

InstitutionJefferies

Times predicted1

Historical Win Rate100.0%

Is money flowing into or out of IMCR?

IMCR holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.39/10 (Outperform).